The Silent Epidemic: Unraveling the Rising Tide of Lung Cancer in Never-Smokers
admin For decades, lung cancer has been inextricably linked with smoking, a deeply ingrained association rooted...
Immunotherapy & CAR-T Research
Cancer Research Institute Ignites Future of Immunotherapy with $2.5 Million Boost, Unveiling New Postdoctoral Fellows
The Cancer Research Institute (CRI) has announced a significant expansion of its commitment to nurturing...
Meet the 2026 STARs: Aaron Whiteley, PhD
The Cancer Research Institute (CRI) has announced the prestigious STAR (Scientists Taking Risks) award for...
World Cancer Support Month Highlights the Indispensable ‘Village’ Behind Every Patient’s Journey to Survivorship.
As the global community observes World Cancer Support Month, attention is critically drawn not only...
Personalized mRNA Cancer Vaccine and Checkpoint Inhibitor Combination Achieves Historic Phase 3 Success in High-Risk Melanoma
For decades, researchers have pursued an ambitious idea: What if a vaccine could teach a...
Susumu Tonegawa, Nobel Laureate and Visionary Immunologist, Passes Away at 86
The global scientific community is profoundly saddened by the passing of Dr. Susumu Tonegawa, a...
Cancer Research Institute Launches Landmark IGNITE Award to Bridge Critical Funding Gap for Next-Generation Immunotherapy Scientists
In a pivotal move to safeguard the future of cancer research, the Cancer Research Institute...
Safeguarding Your Skin: July Marks Ultraviolet Radiation Safety Awareness Month Amidst Immunotherapy Breakthroughs
July serves as a critical period for public health, designated as Ultraviolet (UV) Radiation Safety...
Advancing the Fight Against Sarcoma: Immunotherapy’s Evolving Role in a Rare and Complex Cancer
Sarcoma, a rare and complex group of cancers originating in the body’s connective tissues, presents...
FDA Grants Accelerated Approval to Tudriqev, Marking a Decade-Plus Milestone in Oncolytic Virus Therapy for Advanced Melanoma
The U.S. Food and Drug Administration (FDA) has announced the accelerated approval of Tudriqev (vusolimogene...
